Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2700 of 3546 entries
View as:

A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™

Phase: N/A Priority: Normal
NCT ID: NCT01597648 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT04126200 Org: User:
Start: 10/07/19 End: 02/12/29 Due: 02/12/30

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00169520 Org: User:
Start: 06/30/04 End: - Due: -

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04318548 Org: User:
Start: 08/25/20 End: 11/21/23 Due: 11/21/24

Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants

Phase: N/A Priority: Normal
NCT ID: NCT00390910 Org: User:
Start: 10/01/06 End: 05/02/08 Due: 05/02/09

An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01267968 Org: User:
Start: 01/11/11 End: 03/16/11 Due: 03/16/12

FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01294566 Org: User:
Start: 11/29/10 End: 03/23/11 Due: 03/23/12

To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold

Phase: N/A Priority: Normal
NCT ID: NCT03005067 Org: User:
Start: 12/29/16 End: 06/07/17 Due: 06/07/18

A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02292732 Org: User:
Start: 02/29/16 End: 05/31/17 Due: 05/31/18

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00423046 Org: User:
Start: 01/24/07 End: 05/14/12 Due: 05/14/13

TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00573170 Org: User:
Start: 02/29/08 End: 08/31/09 Due: 08/31/10

Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom

Phase: N/A Priority: Normal
NCT ID: NCT01953822 Org: User:
Start: 10/31/13 End: 08/31/14 Due: 08/31/15

Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02502734 Org: User:
Start: 09/07/15 End: 12/21/15 Due: 12/21/16

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05277051 Org: User:
Start: 03/22/22 End: 09/12/28 Due: 09/12/29

Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars

Phase: N/A Priority: Normal
NCT ID: NCT01978301 Org: User:
Start: 04/15/14 End: 02/05/15 Due: 02/05/16

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00839527 Org: User:
Start: 02/28/09 End: 04/30/13 Due: 04/30/14

The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity(DH)

Phase: N/A Priority: Normal
NCT ID: NCT02751450 Org: User:
Start: 02/01/16 End: 06/17/16 Due: 06/17/17

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults

Phase: N/A Priority: Normal
NCT ID: NCT00730795 Org: User:
Start: 01/31/04 End: - Due: -

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01008956 Org: User:
Start: 04/30/10 End: 10/31/10 Due: 10/31/11

Study Of 323U66 SR In Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00135512 Org: User:
Start: 12/01/04 End: 05/28/07 Due: 05/28/08

Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination

Phase: N/A Priority: Normal
NCT ID: NCT02064504 Org: User:
Start: 02/19/14 End: 05/20/14 Due: 05/20/15

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT04292912 Org: User:
Start: 09/07/20 End: 04/11/22 Due: 04/11/23

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007

Phase: N/A Priority: Normal
NCT ID: NCT01563146 Org: User:
Start: 02/01/16 End: 12/31/17 Due: 12/31/18

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs

Phase: N/A Priority: Normal
NCT ID: NCT01475851 Org: User:
Start: 12/31/11 End: 10/31/14 Due: 10/31/15

A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

Phase: N/A Priority: Normal
NCT ID: NCT02757950 Org: User:
Start: 07/14/16 End: 05/31/17 Due: 05/31/18